Introduction
Polymeric micellar nanocontainers for encapsulating and delivering drugs and biopolymers in living organisms allow: i) creating water-soluble forms of poorly soluble drugs, ii) ensuring a long-term circulation of drugs in a bloodstream, iii) preventing the rapid degradation of drugs in the enzymatic and metabolic processes, iv) reducing essentially therapeutic doses of drugs, v) protecting healthy organs and tissues of the body from the destructive action of toxic drugs, especially at cancer chemotherapy, and vi) avoiding the immune system response to the introduction of foreign proteins and nucleic acids [1] [2] [3] [4] [5] [6] [7] [8] . In the presence of special ligands (vectors), such micellar nanocontainers are capable of targeted drug delivering and providing their controlled release in certain organs, tissues or cells [9] [10] [11] [12] [13] .
Thus, the polymeric micelles can be considered as one of the most convenient and promising delivery vehicles.
In a clinical practice, doxorubicin (Dox) is widely applied for cancer treatment due to powerful action on a wide range of tumour cells.
However, a high toxicity of the drug limits its use because of serious adverse complications, especially in the cardiovascular system [14] [15] .
That is why in recent years, much attention is devoted to the development of suitable micelle carriers for Dox delivery, which can improve its therapeutic efficacy and minimize side effects.
Initially, to create the polymeric micelle carriers the classical amphiphilic block copolymers capable of self-assembly in aqueous medium, were used. They were generally based on the blocks of poly(ethylene oxide) and poly(propylene oxide), polyaminoacids, polycaprolactone, polylactides, etc. [11, [16] [17] .
During past decade a number of polymeric micelles with the cross-linked "core" were presented as potential nanocarries for Dox. copolymers [18] [19] [20] .
In present study, the polymeric micelles of a special type were examined as potential carriers for Dox. They were formed by the asymmetric diblock (DBC) and triblock (TBC) 
Experimental part

Materials
Monomethyl ether of poly(ethelene glycol) (MEPEG) with Mn=5 kDa from "Fluka"
(Germany) as well as poly(ethylene glycol) (PEG) with Mn=6 kDa and ammonium cerium (IV) nitrate from "Aldrich" (USA) were used as received. Monomer acrylamide (AAm)
produced by "Merck" (Germany) was twice recrystallized from chlorophorm before the block copolymer syntheses. Doxorubicin was purchased from "Veropharm" Company (Russia) and used in the hydrochloride form. 
General
Results and discussion
Previously, it was found that the process 1) The molecular weight of TBC was calculated as: МnTBC=MnPЕО+2МnPААm.
2) The weight fraction of (ME)PEO block.
3) The ratio between the number of units in PААm and (ME)PEO blocks.
where Table 2 . The effective length () of the trans-multimers of amide groups (structure 2) was also defined using known relation: =А1679/А1694 [23, 24] .
According to Table 2 , an additional feature of the hydrogen bond system in TBChydr film as compared to PAAm can be noted. Figure 3 and the -G values were calculated by the (3) relation [27] :
The obtained micelle parameters are collected in Table 3 Polymolecular micelles of DBC and TBC had a large "corona" due to which they could be attributed to so-called "hairy"
micelles [27] . TEM images showed also separate micelle aggregates resulted from combining their "coronas".
In order to encapsulate the anticancer drug Dox, we used aqueous solutions of the block copolymers with C=1 kgm ) that opens the prospects for an essential decrease in drug dose at the chemotherapy.
Conclusions
The polymeric micelles of a special type were obtained and evaluated as potential 
